We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Editorial for the Special Issue: "Epidemiology, Prognosis and Antimicrobial Treatment of Extensively Antibiotic-Resistant Bacterial Infections".
- Authors
Karakonstantis, Stamatis; Kritsotakis, Evangelos I.
- Abstract
34439062 8 Losito A.R., Raffaelli F., Del Giacomo P., Tumbarello M. New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review. The increasing consumption of broad-spectrum antimicrobials is fuelling a vicious cycle leading to extensively drug-resistant (XDR) and pandrug-resistant (PDR) bacteria [[1]]. Azithromycin is an interesting option, providing an alternative oral treatment against I P. aeruginosa i (fluoroquinolones currently being the only oral option), as well as a potential option against XDR GNB. Nevertheless, macrolides have also been used successfully as prophylactic therapy in patients with cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease, showing particular benefit in I P. aeruginosa i -colonized patients [[13], [15]].
- Subjects
BRONCHIECTASIS; BACTERIAL diseases; PROGNOSIS; ANTIMICROBIAL peptides; INFECTION prevention
- Publication
Antibiotics (2079-6382), 2022, Vol 11, Issue 6, p804
- ISSN
2079-6382
- Publication type
Editorial
- DOI
10.3390/antibiotics11060804